Publication | Closed Access

Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet

ObesityMetabolic SyndromeInflammationNonalcoholic Fatty Liver DiseaseMedicineLiver PhysiologyImmunologyNlrp3 Inflammasome ActivationHepatotoxicityHigh-fat DietFatty Liver DiseaseMetabolismPharmacologyDrug-induced Liver InjuryMouse ModelLipid SynthesisOxidative StressHealth Sciences